| [1] |
Vicki Plaks, Charlotte D, Koopman, et al. Circulating Tumor Cells [J]. Science, 2013, 341(6151): 1186-1188.
|
| [2] |
Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micrometastases [J]. Nat Rev Clin Oncol, 2009, 6(6): 339-351.
|
| [3] |
Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis [J]. Science, 2011, 331(6024): 1559-1564.
|
| [4] |
Baccelli I, Schneeweiss A, Riethdorf S, et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay [J]. Nat Biotechnol, 2013, 31(6): 539-544.
|
| [5] |
Berezovskaya O, Schimmer AD, Glinskii AB, et al. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells [J]. Cancer Res, 2005, 65(6): 2378-2386.
|
| [6] |
Hou JM, Greystoke A, Lancashire L, et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy [J]. Am J Pathol, 2009, 175(2): 808-816.
|
| [7] |
Gazzaniga P, Gianni W, Raimondi C, et al. Circulating tumor cells in high-risk nonmetastatic colorectal cancer [J]. Tumour Biol, 2013, 34(5): 2507-2509.
|
| [8] |
Kling J. Beyond counting tumor cells [J]. Nat Biotechnol, 2012, 30(7): 578-580.
|
| [9] |
Yu M, Stott S, Toner M, et al. Circulating tumor cells: approaches to isolation and characterization [J]. J Cell Biol, 2011, 192(3): 373-382.
|
| [10] |
Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions [J]. Cancer Lett, 2007, 253(2): 180-204.
|
| [11] |
Gormally E, Caboux E, Vineis P, et al. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance [J]. Mutat Res, 2007, 635(2-3): 105-117.
|
| [12] |
Schwarzenbach H, Chun FK, Lange I, et al. Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer [J]. Int J Cancer, 2007, 120(7): 1465-1471.
|
| [13] |
Schwarzenbach H, Alix-Panabières C, Müller I, et al. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer [J]. Clin Cancer Res, 2009, 15(3): 1032-1038.
|
| [14] |
Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumor cells [J]. Nat Rev Cancer, 2008, 8(5): 329-340.
|
| [15] |
Mohamed H, Murray M, Turner JN, et al. Isolation of tumor cells using size and deformation [J]. J Chromatogr A, 2009, 1216(47): 8289-8295.
|
| [16] |
Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells [J]. Am J Pathol, 2000, 156(1): 57-63.
|
| [17] |
Marrinucci D, Bethel K, Bruce RH, et al. Case study of the morphologic variation of circulating tumor cells [J]. Hum Pathol, 2007, 38(3): 514-519.
|
| [18] |
Zheng S, Lin H, Liu JQ, et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells [J]. J Chromatogr A, 2007, 1162(2): 154-161.
|
| [19] |
Mejean A, Vona G, Nalpas B, et al. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence [J]. J Urol, 2000, 163(6): 2022-2029.
|
| [20] |
Riethdorf S, Fritsche H, Müller V, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the Cell Search system [J]. Clin Cancer Res, 2007, 13(3): 920-928.
|
| [21] |
Attard G, Swennenhuis JF, Olmos D, et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer [J]. Cancer Res, 2009, 69(7): 2912-2918.
|
| [22] |
Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology [J]. Nature, 2007, 450(7173): 1235-1239.
|
| [23] |
Shannon L. Stott, Chia-Hsien Hsu, Dina I. Tsukrov, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip [J]. Proc Natl Acad Sci U.S.A, 2010,107(43): 18392-18397.
|
| [24] |
Orfao A, Rodríguez C, Adansa JC, et al. Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples [J]. Am J Clin Pathol, 2005, 123(1): 66-74.
|
| [25] |
Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation [J]. Cell, 2012, 148(1-2): 349-361.
|
| [26] |
Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition [J]. Science, 2013, 339(6119): 580-584.
|
| [27] |
Haraguchi N, Ohkuma M, Sakashita H, et al. CD133＋CD44＋population efficiently enriches colon cancer initiating cells [J]. Ann Surg Oncol, 2008, 15(10): 2927-2933.
|
| [28] |
Pang R, Law WL, Chu AC, et al. A subpopulation of CD26＋ cancer stem cells with metastatic capacity in human colorectal cancer [J]. Cell Stem Cell, 2010, 6(6): 603-615.
|
| [29] |
Ahmed MA, Al-Attar A, Kim J, et al. CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer [J]. J Clin Pathol, 2009, 62(12): 1117-1122.
|
| [30] |
Lugli A, Iezzi G, Hostettler I, et al. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer [J]. Br J Cancer, 2010, 103(3): 382-390.
|
| [31] |
Pachmann K, Camara O, Kavallaris A, et al. Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring [J]. Breast Cancer Res, 2005a, 7(6): R975-R979.
|
| [32] |
He W, Wang H, Hartmann LC, et al. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry [J]. Proc Natl Acad Sci USA, 2007,104(28): 11760-11765.
|
| [33] |
Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells [J]. N Engl J Med, 2008, 359(4): 366-377.
|
| [34] |
Botteri E, Sandri MT, Bagnardi V, et al. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer [J]. Breast Cancer Res Treat, 2010, 122(1): 211-217.
|
| [35] |
de Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer [J]. Clin Cancer Res, 2008, 14(19): 6302-6309.
|
| [36] |
Cohen SJ, Alpaugh RK, Gross S, et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer [J]. Clin Colorectal Cancer, 2006, 6(2): 125-132.
|
| [37] |
Ignatiadis M, Xenidis N, Perraki M, et al. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer [J]. J Clin Oncol, 2007, 25(33): 5194-5202.
|
| [38] |
Cohen SJ, Alpaugh RK, Gross S, et al. Isolation and characterization of circulating tumor cells from localized and metastatic prostate cancer patients [J]. Sci Transl Med, 2010a, 2(25): 25ra23.
|
| [39] |
Pierga JY, Bidard FC, Mathiot C, et al. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial [J]. Clin Cancer Res, 2008, 14(21): 7004-7010.
|